다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Cancer cell international, v.6, 2006년, pp.20 - 20
Eto, Isao (Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, Alabama, USA)
AI-Helper
Backgroundp27(Kip1) is a cyclin-dependent kinase inhibitor. When up-regulated, p27 inhibits G1-to-S phase transition of the cell cycle. This report addresses the question of whether various nutritional and chemopreventive anti-cancer agents up-regulate the expression of p27 in preneoplastic and neop...
Hengst L A second RING to destroy p27 Kip1 Nature Cell Biol 2004 6 1153 1155 15573093 10.1038/ncb1204-1153
Albanese C Johnson J Watanabe G Eklund N Vu D Arnold A Pestell RG Transforming p21 ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions J Biol Chem 1995 270 23589 23597 7559524 10.1074/jbc.270.31.18301
Henglein B Chenivesse X Wang J Eick D Brechot C Structure and cell cycle-regulated transcription of the human cyclin A gene Proc Natl Acad Sci USA 1994 91 5490 5494 8202514 10.1073/pnas.91.12.5490
Minami S Ohtani-Fujita N Igata E Tamaki T Sakai T Molecular cloning and characterization of the human p27 Kip1 gene promoter FEBS Lett 1997 411 1 6 9247132 10.1016/S0014-5793(97)00660-1
Kullmann M Gopfert U Siewe B Hengst L ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5'UTR Genes Dev 2002 16 3087 3099 12464637 10.1101/gad.248902
Gopfert U Kullmann M Hengst L Cell cycle-dependent translation of p27 involves a responsive element in its 5'-UTR that overlaps with a uORF Hum Mol Genet 2003 12 1767 1779 12837699 10.1093/hmg/ddg177
el-Deiry WS Tokino T Velculescu VE Levy DB Parsons R Trent JM Lin D Mercer WE Kinzler KW Vogelstein B WAF1, a potential mediator of p53 tumor suppression Cell 1993 75 817 825 8242752 10.1016/0092-8674(93)90500-P
Hsu TC Nair R Tulsian P Camalier CE Hegamyer GA Young MR Colburn NH Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-κB activation Cancer Res 2001 61 4160 4168 11358840
Liu Z Kokunai T Tamaki N Tamoxifen interacts with NEU/c-ERBB-2 receptor and inhibits growth of human malignant glioma cell lines Kobe J Med Sci 2001 47 131 140 11729374
Nedeljkovic A Radulovic S Bjelogrlic S Pleiotropic effect of genistein makes it a promising cancer protective compound Arch Oncol 2001 9 171 174
Sah JF Balasubramanian S Eckert RL Rorke EA Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and Akt kinases J Biol Chem 2004 279 12755 12762 14701854 10.1074/jbc.M312333200
Masuda M Suzui M Lim JT Weinstein IB Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells Clin Cancer Res 2003 9 3486 3491 12960141
Inoki K Corradetti MN Guan KL Dysregulation of the TSC-mTOR pathway in human disease Nature Genetics 2005 37 19 24 15624019 10.1038/ng1494
Ohanna M Sobering AK Lapointe T Lorenzo L Praud C Petroulakis E Sonenberg N Kelly PA Sotiropoulos A Pende M Atrophy of S6K1-/- skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control Nature Cell Biol 2005 7 286 294 15723049 10.1038/ncb1231
Zhou G Myers R Li Y Chen Y Shen X Fenyk-Melody J Wu M Ventre J Doebber T Fujii N Musi N Hirshman MF Goodyear LJ Moller DE Role of AMP-activated protein kinase in mechanism of metformin action J Clin Invest 2001 108 1167 1174 11602624 10.1172/JCI200113505
Agrawal D Hauser P McPherson F Dong F Garcia A Pledger WJ Repression of p27Kip1 synthesis by platelet-derived growth factor in BALBc/3T3 cells Mol Cell Biol 1996 16 4327 4336 8754833
Hengst L Reed SI Translational control of p27Kip1 accumulation during the cell cycle Science 1996 271 1861 1864 8596954
Millard SS Yan JS Nguyen H Pagano M Kiyokawa H Koff A Enhanced ribosomal association of p27(Kip1) mRNA in a mechanism contributing to accumulation during growth arrest J Biol Chem 1997 272 7093 7098 9054402 10.1074/jbc.272.11.7093
Miskimins WK Wang G Hawkinson M Miskimins R Control of cyclin-dependent kinase inhibitor p27 expression by cap-independent translation Mol Cell Biol 2001 21 4960 4967 11438653 10.1128/MCB.21.15.4960-4967.2001
Millard SS Vidal A Markus M Koff A A U-rich element in the 5' untranslated region is necessary for the translation of p27 mRNA Mol Cell Biol 2000 20 5947 5959 10913178 10.1128/MCB.20.16.5947-5959.2000
Hardie DG AMP-activated protein kinase: the guardian of cardiac energy status J Clin Invest 2004 114 465 468 15314681 10.1172/JCI200422683
Hardie DG The AMP-activated protein kinase pathway – new players upstream and downstream J Cell Sci 2004 117 5479 5487 15509864 10.1242/jcs.01540
Nicholson KM Anderson NG The protein kinase B/Akt signaling pathway in human malignancy Cell Signal 2002 14 381 395 11882383 10.1016/S0898-6568(01)00271-6
Hinault C Mothe-Satney I Gautier N Lawrence JC Jr Van Obberghen E Amino acids and leucine allow insulin activation of the PKB/mTOR pathway in normal adipocytes treated with wortmannin and in adipocytes from db/db mice FASEB J 2004 18 1894 1896 15479767
Knauf U Tschopp C Gram H Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2 Mol Cell Biol 2001 21 5500 5511 11463832 10.1128/MCB.21.16.5500-5511.2001
Shatkin AJ Manley JL The ends of the affair: capping and polyadenylation Nat Struct Biol 2000 7 838 842 11017188 10.1038/79583
Shuman S Lima CD The polynucleotide ligase and RNA capping enzyme superfamily of covalent nucleotidyltransferases Curr Opin Struct Biol 2004 14 757 764 15582400 10.1016/j.sbi.2004.10.006
Gu M Lima CD Processing the message: structural insights into capping and decapping mRNA Curr Opin Struct Biol 2005 15 99 106 15718140 10.1016/j.sbi.2005.01.009
Holstein SA Wohlford-Lenane CL Hohl RJ Consequences of mevalonate depletion. Differential transcriptional, translational, and post-translational up-regulation of Ras, Rap1a, RhoA, and RhoB J Biol Chem 2002 277 10678 10682 11788600 10.1074/jbc.M111369200
Jiang H Coleman J Miskimins R Miskimins WK Expression of constitutively active 4EBP-1 enhances p27Kip1 expression and inhibits proliferation of MCF7 breast cancer cells Cancer Cell Int 2003 3 2 12633504 10.1186/1475-2867-3-2
King TD Song L Jope RS AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3 Biochem Pharmacol 2006 71 1637 1647 16620785 10.1016/j.bcp.2006.03.005
Hahn-Windgassen A Nogueira V Chen CC Skeen JE Sonenberg N Hay N Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity J Biol Chem 2005 280 32081 32089 16027121 10.1074/jbc.M502876200
Suzuki A Kusakai G Kishimoto A Shimojo Y Ogura T Lavin MF Esumi H IGF-1 phosphorylates AMPKα subunit in ATM-dependent and LKB1-independent manner Biochem Biophys Res Commun 2004 324 986 992 15485651 10.1016/j.bbrc.2004.09.145
Dokladda K Green KA Pan DA Hardie DG PD98059 and U0126 activate AMP-activated protein kinase by increasing the cellular AMP:ATP ratio and not via inhibition of the MAP kinase pathway FEBS Lett 2005 579 236 240 15620719 10.1016/j.febslet.2004.11.084
Rattan R Giri S Singh AK Singh I 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase J Biol Chem 2005 280 39582 39593 16176927 10.1074/jbc.M507443200
Longnus SL Segalen C Giudicelli J Sajan MP Farese RV Van Obberghen E Insulin signaling downstream of protein kinase B is potentiated by 5'AMP-activated protein kinase in rat hearts in vivo Diabetologia 2005 48 2591 2601 16283248 10.1007/s00125-005-0016-3
Han S Khuri FR Roman J Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways Cancer Res 2006 66 315 323 16397245 10.1158/0008-5472.CAN-05-2367
Davis BJ Xie Z Viollet B Zou MH Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase Diabetes 2006 55 496 505 16443786 10.2337/diabetes.55.02.06.db05-1064
Hattori Y Suzuki K Hattori S Kasai K Metformin inhibits cytokine-induced factor κB activation via AMP-activated protein kinase activation in vascular endothelial cells Hypertension 2006 47 1183 1188 16636195 10.1161/01.HYP.0000221429.94591.72
Soltys CL Kovacic S Dyck JR Activation of cardiac AMP-activated protein kinase by LKB1 expression or chemical hypoxia is blunted by increased Akt activity Am J Physiol Heart Circ Physiol 2006 290 H2472 H2479 16428351 10.1152/ajpheart.01206.2005
Dagon Y Avraham Y Berry EM AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2α in adipocytes Biochem Biophys Res Commun 2006 340 43 47 16377306
Jun T Gjoerup O Roberts TM Tangled web: evidence of cross-talk between c-Raf-1 and Akt Sci STKE 1999 1999 PE1 11865188
Sprenkle AB Davies SP Carling D Hardie DG Sturgill TW Identification of Raf-1 Ser621 kinase activity from NIH 3T3 cells as AMP-activated protein kinase FEBS Lett 1997 403 254 258 9091312 10.1016/S0014-5793(97)00062-8
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.